PRESS-RELEASE ·Filed Nov 16, 2026
Press release · FDA
CRVO drugs
CRVO drug pipeline →Price Chart
Loading chart...
Investment Themes
Documents Analyzed
This report is based on 1 press release from GlobeNewswire.
| Document | Accession Number |
|---|---|
| PRESS-RELEASE Data (Synthetic) | press-3404092 |
Track record
26 reports on CRVO
12 of 13 bullish or bearish reports moved the stock their way by T+1. Best: +40.68% at T+60 after the Jun 18, 2026 report. 12 of 13 went positive at some point.
Filters
- Nov 16, 2026today Press Release Neutral 4/10 Viewing Entry $1.74 Now $1.67 −3.75% settles Nov 18
- Nov 9, 20267d ago Press Release Neutral 4/10 Entry $1.43 to $1.37 Now $1.67 +16.78% ▼ −4.20% −3.83% vs SPY
- Oct 29, 202618d ago 8-K Neutral 5/10 Entry $1.60 to $1.64 Now $1.67 +4.37% ▲ +2.50% +2.98% vs SPY
- Oct 14, 20264w ago 8-K Neutral 2/10 Entry $2.25 to $2.24 Now $1.67 −25.78% ▼ −0.44% +0.66% vs SPY
- Oct 13, 20264w ago 8-K Bullish 6/10 Entry $2.27 to $2.29 Now $1.67 −26.43% ▲ +0.88% +1.96% vs SPY
- Oct 9, 20265w ago 8-K Neutral 2/10 Entry $2.51 to $2.27 Now $1.67 −33.47% ▼ −9.56% −9.55% vs SPY
- Sep 10, 20269w ago Press Release Bullish 5/10 Entry $2.48 to $2.57 Now $1.67 −32.66% ▲ +3.63% +2.78% vs SPY
- Aug 10, 202614w ago 8-K Neutral 4/10 Entry $3.09 to $3.07 Now $1.67 −45.95% ▼ −0.65% −0.90% vs SPY
- Aug 4, 202614w ago 8-K Bullish 6/10 Entry $2.80 to $2.81 Now $1.67 −40.36% ▲ +0.36% +0.56% vs SPY
- Aug 4, 202614w ago Press Release Bullish 4/10 Entry $2.80 to $2.81 Now $1.67 −40.36% ▲ +0.36% +0.56% vs SPY
Showing 10 of 26
US Market Status
Market Closed · Opens Wed (10h 49m)
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers